Core Viewpoint - The company, Duorui Pharmaceutical, emphasizes its commitment to establishing a robust corporate governance structure and enhancing communication with investors, particularly small and medium shareholders [1] Group 1: Corporate Governance - The company will adhere to the requirements of the Company Law, the Code of Corporate Governance for Listed Companies, and other relevant laws and regulations to establish a governance structure composed of the shareholders' meeting, board of directors, and management [1] - There will be efforts to further improve related systems to ensure effective governance [1] Group 2: Investor Communication - The company plans to strengthen communication with investors through various channels, actively engaging with shareholders, especially small and medium shareholders, to gather their opinions and demands [1] - The company commits to timely responses to concerns raised by small and medium shareholders [1] Group 3: Information Disclosure - The company aims to continuously enhance the quality of information disclosure, ensuring that it is truthful, accurate, complete, timely, and fair [1]
多瑞医药：公司将进一步加强与投资者的沟通